Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
An accessible primer on stock index levels, detailing what they represent, how they’re calculated, and why they matter for portfolio assessment.
20,792 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
AI is advancing beyond chips. NVIDIA's networking revenue just signals a broader shift to end-to-end AI infrastructur...
Discover how Owens Corning 2025 earnings shape the stock's outlook. This guide breaks down Q4 results, margins, and t...
A focused look at Toast's Q1 2026 results and what they imply for toast (tost) 2026 earnings. Expect discussion of re...
Michigan drivers are feeling the pinch as gas prices rise. This article explains the root causes, the economic ripple...
Investors are watching Health Catalyst as healthcare data analytics gain budget priority. This guide breaks down what...
Analysts and investors are watching KLXE's Q1 2026 earnings closely. This article breaks down the transcript, interpr...
A global moment at a formal state dinner showed how a CEO's public image can ripple into your wallet. Learn how to tu...
Alphabet is quietly pivoting its AI strategy toward a new growth engine something. This shift could tilt Google Cloud...
Wells Fargo lowers Amazon's price target to $312 while keeping an Overweight rating, highlighting AWS as the core eng...
Stocks closed higher for an eighth straight week as earnings buoy sentiment, even as a key consumer confidence gauge ...
Micron Technology posted a surprisingly strong AI memory quarter, triggering debate over whether the stock’s 7x forwa...